Početna › Akutna bifentipska leukemija › Illinois › Chicago

Kliničke studije za Akutna bifentipska leukemija u gradu Chicago, IL

7 studija za Akutna bifentipska leukemija traži sudionike na lokacijama u gradu Chicago i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

U tijeku regrutacijaFaza 2

Lurie Children's Hospital-Chicago, Chicago
University of Chicago Comprehensive Cancer Center, Chicago

365 Days · Oba spola · Ažurirano 25. ruj 2026. · NCT06317662

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

U tijeku regrutacijaFaza 1/2

The University of Chicago Medical Center, Chicago

30 Days · Oba spola · Ažurirano 16. ruj 2026. · NCT04065399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

U tijeku regrutacijaFaza 3

Lurie Children's Hospital-Chicago, Chicago
University of Illinois, Chicago
University of Chicago Comprehensive Cancer Center, Chicago

365 Days – 25 Years · Oba spola · Ažurirano 25. kol 2026. · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

U tijeku regrutacijaFaza 1/2

Lurie Children's Hospital-Chicago, Chicago
University of Illinois, Chicago
University of Chicago Comprehensive Cancer Center, Chicago

Do 22 godina · Oba spola · Ažurirano 25. kol 2026. · NCT04726241

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

U tijeku regrutacijaFaza 1/2

University of Illinois at Chicago Cancer Center, Chicago

Od 12 do 95 godina · Oba spola · Ažurirano 15. tra 2026. · NCT04329728

Venetoclax Basket Trial for High Risk Hematologic Malignancies

U tijeku regrutacijaFaza 1

Ann & Robert H Lurie Children's Hospital of Chicago, Chicago

Od 1 do 40 godina · Oba spola · Ažurirano 12. ožu 2026. · NCT05292664

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

U tijeku regrutacijaFaza 1

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

Od 1 do 21 godina · Oba spola · Ažurirano 6. pro 2024. · NCT05476770

Studije za Akutna bifentipska leukemija u drugim gradovima

Ostale studije u gradu Chicago

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.